• Hello Guest,
    We are experiencing difficulties in sending emails. It related to our platform and how it handles the requests. We are working on it. For now, we are using manual methods in sending emails. Please check your SPAM folder as well. Please let me know if you're still experiencing any issue? Use the Contact US at the bottom of the page to reach out.

    Best regards,
    VETeLiB Admin

PhD Cysteinyl Leukotrienes Dependent [Ca2+]i Responses to Angiotensin II in Rat Cardiomyocytes

whisper

Member
Joined
Jul 1, 2012
Messages
165
Reaction score
16
Points
16
Iraq Professor at Vet School
Cysteinyl Leukotrienes Dependent [Ca2+]i Responses to Angiotensin II in Rat Cardiomyocytes and Aortic Smooth Muscle Cells
Pinggang Liu, MD
Abstract
Angiotensin II (Ang II) plays a very important role in regulating cardiac and vascular contraction and proliferation/hypertrophy via stimulation of AT1 receptors. A few studies have demonstrated that 5-lipoxygenase (5-LO) derived cysteinyl leukotrienes (CysLT) contribute to Ang II evoked tension responses in rat aortic rings. Whether CysLT would contribute to Ang II evoked Ca2+ mobilization in neonatal rat cardiomyocytes (NRC) and rat aortic smooth muscle cells (ASMC) has not been investigated. In the present study, using primary cultures of NRC and minimally passaged cultures of rat ASMC, an effort was made to address this key issue. The agonists evoked increase in cytosolic free calcium ([Ca2+]i) level was determined by fura-2 fluorescence measurement in NRC and ASMC. Total CysLT levels in the culture medium were determined using an ELISA kit. CysLT1/CysLT2 receptor mRNA levels of NRC and ASMC were quantified by Northern blot analysis. In NRC, the AT1 but not the AT2 selective antagonist, attenuated the elevations in [Ca2+]i and CysLT levels evoked by Ang II. Vasopressin (AVP) and endothelin-1 (ET-1) increased [Ca2+]i but not CysLT levels. The 5-LO inhibitor, AA861, and the CysLT1 selective antagonist, MK-571, reduced the maximal [Ca2+]i responses (Emax) to Ang II but not to AVP and ET-1. While CysLT1 antagonist reduced the Emax to leukotriene D4, (LTD4), the dual CysLT1/CysLT2 antagonist, BAY u9773, completely blocked the [Ca2+]i elevation to both LTD4 and leukotriene C4 (LTC4). Both CysLT1 and CysLT2 mRNA were detected in NRC.
Pages:200

[thanks-thanks]pdf,1.91MB,http://depositfiles.com/files/lovy7ba8a[/thanks-thanks]
 
Last edited:
Back
Top